Ken Griffin Teva Pharmaceutical Industries LTD Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 1,131,400 shares of TEVA stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,131,400
Previous 3,914,400
71.1%
Holding current value
$18.7 Million
Previous $86.3 Million
79.84%
% of portfolio
0.0%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
627MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$711 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$646 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$625 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$483 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$461 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...